Male Sexual Function: A Guide to Clinical ManagementJohn J. Mulcahy Springer Science & Business Media, 16 de nov. de 2007 - 494 páginas The first edition of Male Sexual Function: A Guide to Clinical Management was published in 2001. Since that time, two new oral medications for erectile dysfunction ® ® (ED), Vardenafil (Levitra ) and Tadalafil (Cialis ), have been introduced. Links between ED and lower urinary tract symptoms have been postulated, advances in the basic science of erectile physiology have occurred, and the appreciation of ED as a form of endothelial dysfunction and a harbinger of other more potentially lethal forms of vascular disease has become more widespread. In some instances, third-party payers have reduced or eliminated coverage for ED treatments in an attempt to cut costs. They have classified sexual activity as “recreational,” “lifestyle,” or not medically necessary, but have failed to appreciate the negative consequences of ED, such as depression with all of its ramifications. Male Sexual Function: A Guide to Clinical Management, Second Edition is a comp- hensive overview of the field of male sexual function and includes a chapter on female sexual dysfunction, an emerging field with a very high incidence in the population and an ever-growing following. |
Conteúdo
18 | |
Epidemiology of Erectile Dysfunction | 47 |
Cardiac Issues Related to Erectile Dysfunction | 61 |
How a Primary Care Clinician Approaches Erectile Dysfunction | 77 |
Hormonal Evaluation and Treatment | 123 |
Female Sexual Dysfunction | 225 |
Evaluation of the Patient With Erectile Dysfunction 253 Jeffrey C La Rochelle and Laurence A Levine | 271 |
Intracavernosal Injection of Vasoactive Agents | 287 |
Penile Implants | 331 |
Vascular Surgery for Erectile Dysfunction 419 | 379 |
History and Medical Therapy | 381 |
Priapism 435 Lawrence S Hakim | 435 |
Ejaculatory Disorders | 447 |
482 | |
Outras edições - Ver todos
Termos e frases comuns
activity agents alprostadil appears artery associated blood cause cavernosal cells changes Clin clinical clinician combination compared cord corporal corpus cylinders decreased demonstrated device diabetes discussion disease disorders drug efficacy ejaculation erectile dysfunction erectile function et al evaluation experience factors half-life hormone human implant impotence improved increased induced inhibition inhibitors initial injection involved issues levels male mechanism myocardial infarction nerve normal occur oral organic pain patients pelvic penile erection penis Peyronie’s disease potential present pressure prevalence priapism problems prostate prostatectomy prosthesis radical radical prostatectomy receptors relationship relaxation reported require response risk role sexual activity sexual dysfunction sexual function side effects significant sildenafil smooth muscle spinal stimulation successful suggested surgery Table testing testosterone therapy tion tissue treated treatment trial Urol Urology vaginal vascular women